[1]
Sourik Shee, Pramod Kumar Manjhi, Shruti Singh, Vikas Maharshi, Sunil Kumar Singh, Alok Kumar and Rajesh Kumar 2026. Suzetrigine: A First-in-Class NaV1.8 Inhibitor – Mechanism and Clinical Trial Evidence for Acute Pain. Asian Pacific Journal of Health Sciences. 13, 3 (Aug. 2026), 87–92. DOI:https://doi.org/10.21276/apjhs.2026.13.3.19.